Paediatric neuropsychiatry - ADHD, OCD & ASD Flashcards
Definition of neuropsychiatric disorders
abnormal behaviours and functional impairment. Categories are descriptive rather than aetiological. Biological, genetic and neurological factors are all important and clinical presentation is shaped by the developmental stage of the child
Common Neuropsychiatric disorders
Hyperactivity, ADHD and hyperkinetic. Autism, autistic spectrum disorders and asbergers. Tourette’s syndrome
OCD. Specific learning disorders
Hyperactivity
Disorders of attention and activity – ADHD (american) is getting stricter but currently up to 10% prevalence while Hyperkinetic disorder (european) is about 1-3%
Diagnostic criteria for hyperactivity
Overactivity – figeting, lack of control etc. Inattention – forgetful, disorganised, distractable etc. Impulsivity – difficulty taking turns, risk taking, interrupting. Occur at two of home/school/clinic. Onset before 7yrs and for >6months Other causes excluded
Epidemiology of hyperactivity
3:1, M/F – more common in inner cities/poor areas
Younger children
Additional features commonly associated with hyperactivity
behavioural problems/conduct disorder/problems with relationships Learning disabilities (10x), specific learning problems, soft neurological signs or developmental delay
Soft neurological signs
clumsiness or neurodevelopmental immaturities
Differential for hyperactive child (6)
May just be a naughty child – situational hyperactivity. Emotional disorders. Tics (tourettes), chorea/dyskineasia, Learning disability
Medical causes
Causes of hyperactivity
Genetics – D4R, DA transporter, fragile X etc. Imaging indicates reduced function in the frontal lobes. Differential response to chemical stimulants suggests it may be a neurochemical imbalance
Psychosocial or diet related factors
Treatment of hyperactivity disorders
Education – both of child, family and school. Behavioural management – ABC and positive reinforcement. Cognitive systems – ‘stop & think’ traffic lights, Medication – stimulants and neuroleptics
Diet (rarely)
Medication to treat hyperactivity
1st line–> stimulants (methylphenidate/dexamphetamine). SEs: low appetite, insomnia, tearfulness, stereotypies/tics. Long term: height reduction. 2nd line –> atomoxetine (NRI), impramine or clonidine (a2 agonist). 3rd line –> Neuroleptics (low dose risperidone)
Prognosis in hyperactivity
Usually wanes in adolescence — can lead to residual problems in adulthood, especially if educational attainment is poor
Can lead to ASPD and drug abuse in adulthood
Epidemiology of autism
2/1000 in adult population of which 10-50% have childhood autism. ASD general prevalence 1%,
3:1 male to female ratio or greater
No relationship with socioeconomic status
Characteristic features of autism/PDD
Social impairment,
Communication impairment
Restricted & repetitive activities or interests
Early onset
Pervasive developmental disorders
a group of five disorders which impact general development
They include: PDD NOS, autism, asbergers, Rett syndrome and childhood dis-intergrative disorder